Fundraising FoxZurex Pharma
Middleton, US · Wisconsin corporation · 2 known investors
Find your way into Zurex Pharma
Sign up to see every warm intro you have to Zurex Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Zurex Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AM
Alexander M. KasperExecutive
CJ
Carmine J. DurhamExecutiveCarmine J. Durham is an executive officer and director at Zurex Pharma with experience in specialty pharmaceuticals and medical devices, including operational roles at both public companies and private startups, capital raising, product development, and corporate transactions.
RA
Roy A. MorganExecutive
Board
MJ
Michael J. LiangBoard director
FA
Frederick A. RobertsonBoard director
RB
Robert B. TruittBoard director
CC
Connie CurranBoard director
Investors · 2
Baird Capitallisted by Baird CapitalChicago
How we know: Baird Capital's portfolio page · a partner's Signal profile · Not right? Tell us
Wisconsin Investment PartnersreportedMadison · $5K – $100K
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$23.9M disclosed across 5 rounds · 2014–2023
▶$3.8MraisedDec 2023 · 14 investors · PharmaceuticalsRule 506(b)
▶$3.8MraisedDec 2023 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Alexander M KasperExecutive Officer, Director
- Frederick A. RobertsonDirector
- Offering amount
- $4M
- Amount sold
- $3.8M
- Minimum investment
- $50K
- First sale
- Dec 2023
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$7.5MraisedJun 2020 · 18 investors · PharmaceuticalsRule 506(b)
▶$7.5MraisedJun 2020 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Frederick A. RobertsonDirector
- Michael J. LiangDirector
- Carmine J DurhamExecutive Officer, Director
- Alexander M KasperExecutive Officer
- Roy Andrew MorganExecutive Officer
- Robert TruittDirector
- Offering amount
- $15M
- Amount sold
- $7.5M
- First sale
- Jun 2020
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$2.2MraisedJun 2018 · 11 investors · PharmaceuticalsRule 506(b)
▶$2.2MraisedJun 2018 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert B. TruittDirector
- Carmine J. DurhamExecutive Officer, Director
- Frederick A. RobertsonDirector
- Andrew MorganExecutive Officer
- Michael J. LiangDirector
- Alexander M. KasperExecutive Officer
- Offering amount
- $3M
- Amount sold
- $2.2M
- First sale
- May 2018
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$6.2MraisedAug 2016 · 26 investors · PharmaceuticalsRule 506(b)
▶$6.2MraisedAug 2016 · 26 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael J. LiangDirector
- Andrew MorganExecutive Officer
- Frederick A. RobertsonDirector
- Robert B. TruittDirector
- Alexander M. KasperExecutive Officer
- Carmine J. DurhamExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $6.2M
- First sale
- Aug 2016
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$4.1MraisedJul 2014 · 13 investors · PharmaceuticalsRule 506(b)
▶$4.1MraisedJul 2014 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael LiangDirector
- Alexander M. KasperExecutive Officer
- Robert B. TruittDirector
- Roy A. MorganExecutive Officer
- Frederick A. RobertsonExecutive Officer, Director
- Connie CurranDirector
- Carmine J. DurhamExecutive Officer, Director
- Offering amount
- $5.1M
- Amount sold
- $4.1M
- First sale
- Jun 2014
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Zurex Pharma's investors?
- Zurex Pharma's investors include Baird Capital, Wisconsin Investment Partners.
- How much funding has Zurex Pharma raised?
- Zurex Pharma has disclosed $23.9M raised across 5 rounds.
- Where is Zurex Pharma headquartered?
- Zurex Pharma is headquartered in Middleton, US.